XWELL (XWEL) AI Stock Analysis

• Market Cap: $4.53M
• Dividend Yield: N/A
• Average Volume (3M): 92.16K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.84
• Revenue Growth: 1.33%
• EPS Growth: 35.82%
• Country: US
• Employees: 246
• Sector: Healthcare
• Sector Strength: 40
• Industry: Personal Products & Services
• EPS (TTM): N/A
• Shares Outstanding: 5,261,024
• 10 Day Avg. Volume: 222,361
• 30 Day Avg. Volume: 92,161
• PEG Ratio: 1.00
• Price to Book (P/B): -5.88
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.36
• Enterprise Value/Market Cap: 2.39
• Enterprise Value/Revenue: 0.08
• Enterprise Value/Gross Profit: 1.25
• Enterprise Value/Ebitda: -0.23
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 40 Underperform
• Price Target: $1.00 ▲(16.28%Upside)

XWELL's overall stock score is primarily influenced by its poor financial performance and unattractive valuation. The financial distress and negative equity are major concerns. The technical indicators show mixed signals, but overall bearish sentiment prevails. While strategic investments could offer future growth, the current risks overshadow potential positives.

XWELL Business Overview & Revenue Model

Company Description

XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.

How the Company Makes Money

XWELL generates revenue through multiple streams primarily centered around its wellness centers and service offerings. The company earns money by providing spa and wellness services, which include massage therapy, skincare treatments, and other health-related services. Additionally, XWELL sells health and wellness products through its retail outlets, contributing to its income. The company may also engage in partnerships with other organizations within the health and wellness industry to expand its service offerings and reach a broader audience, further supporting its revenue generation.

XWELL Financial Statement Overview

Summary

XWELL is facing significant financial challenges, with declining revenue and profitability metrics. The balance sheet shows weakened financial health with negative equity, and cash flow issues persist, reflecting operational inefficiencies and liquidity concerns.

Income Statement

The company's revenue has decreased significantly over the years, with a notable decline from 2021 to 2023. Gross profit margin improved slightly in 2023 compared to 2022, but remains weak at 26.3%. Net profit margin is negative, indicating consistent losses. EBIT and EBITDA margins are also negative, reflecting operational challenges despite some improvement in EBIT in 2024.

Balance Sheet

The company has a negative stockholders' equity in 2024, indicating financial distress. The debt-to-equity ratio is not meaningful due to negative equity. The equity ratio is also negative, signaling potential solvency issues. Total assets have decreased significantly, impacting the company's financial stability.

Cash Flow

Operating cash flow is negative, indicating cash outflows from operations. Free cash flow is also negative, reflecting ongoing financial strain. Cash flow from financing activities has been inconsistent, with a significant drop in 2024. The operating cash flow to net income ratio suggests poor cash generation relative to net income.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
33.90M	30.11M	55.94M	73.73M	8.38M
	Gross Profit
8.92M	3.68M	12.05M	32.43M	-3.60M
	EBIT
69.00K	-19.30M	-24.55M	5.87M	-40.10M
	EBITDA
-15.96M	-15.75M	-19.12M	7.87M	-19.54M
	Net Income Common Stockholders
-16.85M	-27.74M	-32.63M	3.35M	-92.23M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
11.80M	23.05M	42.19M	105.51M	89.80M
	Total Assets
25.35M	38.99M	70.43M	127.27M	103.13M
	Total Debt
10.77M	11.09M	14.11M	13.82M	15.38M
	Net Debt
6.22M	2.66M	-4.93M	-91.68M	-74.42M
	Total Liabilities
17.61M	18.02M	22.48M	27.33M	22.76M
	Stockholders Equity
-788.00K	13.00M	39.93M	92.73M	77.81M
Cash Flow		Free Cash Flow
-12.80M	-18.45M	-31.02M	6.97M	-29.36M
	Operating Cash Flow
-11.01M	-16.07M	-24.19M	15.64M	-25.01M
	Investing Cash Flow
5.89M	5.65M	-34.84M	-6.24M	-4.35M
	Financing Cash Flow
1.36M	8.00K	-27.38M	6.35M	117.22M

XWELL Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.86
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XWEL, the sentiment is Negative. The current price of 0.86 is below the 20-day moving average (MA) of 0.86, below the 50-day MA of 0.89, and below the 200-day MA of 1.37, indicating a bearish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 48.18 is Neutral, neither overbought nor oversold. The STOCH value of 21.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XWEL.

XWELL Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RGS	65 Neutral	$56.93M	0.62	548.07%	―	-4.88%	―
MRM	61 Neutral	$11.14M	8.02	23.48%	―	12.93%	66.81%
MED	57 Neutral	$147.39M	66.49	-3.32%	―	-39.47%	-110.28%
Sector *	53 Neutral	$5.14B	3.23	-45.01%	2.85%	17.55%	-0.69%
TRNR	47 Neutral	$8.11M	―	-446.50%	―	445.72%	84.92%
XWEL	40 Underperform	$4.53M	―	-797.66%	―	1.33%	35.82%
WGHTQ	33 Underperform	$22.72M	―		―	-10.33%	79.59%

XWELL Corporate Events

XWELL Faces Nasdaq Delisting Risk Over Bid Price

On May 13, 2025, XWELL, Inc. received a notification from the Nasdaq Stock Market indicating that the company’s common stock did not meet the minimum bid price requirement of $1.00 per share over a 30-day period, which is necessary for continued listing on the Nasdaq Capital Market. XWELL has been given a compliance period until November 10, 2025, to meet this requirement by maintaining a minimum closing bid price of $1.00 for at least ten consecutive business days. If XWELL fails to comply within this period, they may qualify for an additional 180-day extension if they meet other listing standards and provide a plan to address the deficiency, potentially through a reverse stock split. The letter does not immediately affect the company’s stock listing, which remains active on Nasdaq.

XWELL Stockholders Approve Key Proposals at Special Meeting

On April 10, 2025, XWELL held a Special Meeting where stockholders voted on five proposals. The meeting saw participation from 3,251,366 shares of common stock. Proposal 1, concerning the issuance of shares to comply with Nasdaq Listing Rule 5635(d), was authorized. Proposal 2, aimed at classifying the board of directors into two classes, was not approved. Proposal 3, which involved amending the Incentive Plan to increase the number of shares available for awards, was approved. Proposal 4, the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for 2025, was ratified. Lastly, Proposal 5, to adjourn the meeting if necessary, was also approved.

XWELL Announces Strategic Investment in Medical Spas

On March 13, 2025, XWELL, Inc. announced a strategic investment plan to acquire select medical spas by the end of 2025, using a $4 million private placement to expand into the wellness and beauty sector. This move aims to position XWELL as a leader in the rapidly growing market by offering advanced, personalized wellness treatments in metropolitan areas like Orlando, Austin, and Salt Lake City, thereby enhancing its brand presence and catering to the rising demand for non-invasive, results-driven beauty and wellness services.